General, 11 April 2019 Partners in the north In 2007, the Nordic EMBL Partnership for Molecular Medicine was founded as a collaboration between EMBL and FIMM (Institute of Molecular Medicine Finland) at the University of Helsinki, MIMS (Laboratory for Molecular Infection Medicine Sweden) at Umeå University, and NCMM (Centre for Molecular Medicine Norway) at the University of Oslo. The collaboration with EMBL aimed to bring their biomedical research to a more international level by raising the profile of their institutes, creating state-of-the-art infrastructures and recruiting excellent scientists from around the world.
Heidelberg, 8 April 2019 Welcome: Joana Witkowski During her career, Joana Witkowski has worked as a fundraiser for organisations such as the Royal Academy of Music and the British Heart Foundation (BHF) in London. Now, the native Heidelberger has returned to her hometown to lead the Office of Resource Development (ORD) at EMBL.
General, 3 April 2019 How EMBL partnerships promote collaboration The EMBL Partnership Programme is an initiative aimed at promoting scientific collaboration across the EMBL member states by setting up close cooperative alliances between EMBL and research institutions in the member states. The Partnership Programme has grown gradually over the years and currently encompasses 11 partnerships. These are based on shared institutional goals and common or complementary scientific interests. The aim is to combine the advantages of the EMBL model with the individual strengths of the partners, creating an interlinked system of institutions working together in the pursuit of scientific excellence.
Heidelberg, 1 April 2019 Global microbial signatures for colorectal cancer Researchers from EMBL, the University of Trento in Italy, and their international collaborators have now analysed multiple existing microbiome association studies of colorectal cancer together with newly generated data. Their meta-analyses establish disease-specific microbiome changes which are globally robust – consistent across seven countries on three continents – despite differences in environment, diet and life style. Georg Zeller from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany: “We used a rigorous machine learning analysis to identify microbial signatures for colorectal cancer. We validated these signatures in early cancer stages and in multiple studies, so they can serve as the basis for future non-invasive cancer screening.”
Heidelberg, 1 April 2019 Foundation stone laid for EMBL Imaging Centre A foundation stone ceremony for the new EMBL Imaging Centre, located on the campus of the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, took place today. The new facility will give researchers access to the most modern microscopy technologies available. It is made possible by a collaboration between the German Federal Ministry of Education and Research (BMBF), the State of Baden-Württemberg (MWK), EMBL, and by further contributions from industry partners (Thermo Fisher Scientific, Leica and ZEISS), as well as by donations from the Boehringer Ingelheim Foundation and Heidelberg Cement. The EMBL Imaging Centre will open in 2021.
Heidelberg, 28 March 2019 New functionalities for cells For the first time, scientists have engineered the complex biological process of translation into a designer organelle in a living mammalian cell. Research by the Lemke group at the European Molecular Biology Laboratory (EMBL) - in collaboration with JGU Mainz and IMB Mainz - used this technique to create a membraneless organelle that can build proteins from natural and synthetic amino acids carrying new functionality. Their results - published in Science on 15 March - allow scientists to study, tailor, and control cellular function in more detail.
General, 26 March 2019 EMBL partners with BRAINCITY EMBL has signed a partnership agreement with BRAINCITY, a new Centre of Excellence for Neural Plasticity and Brain Disorders, in Poland. EMBL partnerships are close cooperative affiliations with national institutes in EMBL member states. This is EMBL’s twelfth partnership and furthers EMBL’s aim to create a network of international centres of scientific excellence and advanced training.
Hinxton, 21 March 2019 PDBe-KB: Comprehensive protein data for drug development EMBL’s European Bioinformatics Institute (EMBL-EBI) and collaborators have launched a new data resource, called Protein Data Bank in Europe Knowledge Base (PDBe-KB), which gives researchers a more comprehensive view of publicly available protein structure data. The PDB archive recently passed 150,000 structures and this resource opens up this growing body of knowledge to the wider life sciences community, including drug discovery researchers.
Rome, 18 March 2019 Welcome: Santiago Rompani Santiago Rompani’s group at EMBL Rome studies the function of visual circuits in the thalamus – a part of the brain involved in relaying sensory signals from our outermost sensory organs like eyes and ears to other brain regions for processing. They investigate how the thalamus takes visual information and converts it to more sophisticated information that can be used to shape behaviour.